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Abstract
Background: Studies on the airway microbiome have been performed using a wide range of laboratory protocols
for high-throughput sequencing of the bacterial 16S ribosomal RNA (16S rRNA) gene. We sought to determine the
impact of number of polymerase chain reaction (PCR) steps (1- or 2- steps) and choice of target marker gene
region (V3 V4 and V4) on the presentation of the upper and lower airway microbiome. Our analyses included
lllumina MiSeq sequencing following three setups: Setup 1 (2-step PCR; V3 V4 region), Setup 2 (2-step PCR; V4
region), Setup 3 (1-step PCR; V4 region). Samples included oral wash, protected specimen brushes and protected
bronchoalveolar lavage (healthy and obstructive lung disease), and negative controls.
Results: The number of sequences and amplicon sequence variants (ASV) decreased in order setup1 > setup2 >
setup3. This trend appeared to be associated with an increased taxonomic resolution when sequencing the V3 V4
region (setup 1) and an increased number of small ASVs in setups 1 and 2. The latter was considered a result of
contamination in the two-step PCR protocols as well as sequencing across multiple runs (setup 1). Although genera
Streptococcus, Prevotella, Veillonella and Rothia dominated, differences in relative abundance were observed across
all setups. Analyses of beta-diversity revealed that while oral wash samples (high biomass) clustered together
regardless of number of PCR steps, samples from the lungs (low biomass) separated. The removal of contaminants
identified using the Decontam package in R, did not resolve differences in results between sequencing setups.
Conclusions: Differences in number of PCR steps will have an impact of final bacterial community descriptions, and
more so for samples of low bacterial load. Our findings could not be explained by differences in contamination
levels alone, and more research is needed to understand how variations in PCR-setups and reagents may be
contributing to the observed protocol bias.
Keywords: Microbiota, Contamination, Low biomass, Respiratory, 16S rRNA gene
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Christine.Drengenes@gmail.com
1Department of Thoracic Medicine, Haukeland University Hospital, Bergen,
Norway
2Department of Clinical Science, Faculty of Medicine, University of Bergen,
Bergen, Norway
Full list of author information is available at the end of the article
Drengenes et al. BMC Genomics            (2021) 22:3 
https://doi.org/10.1186/s12864-020-07252-z
Background
The bacterial airway microbiome has been studied using
a wide range of protocols for high-throughput sequen-
cing of the bacterial 16S ribosomal RNA (16S rRNA)
gene. Common to all amplicon based protocols is the
application of the polymerase chain reaction (PCR) for i)
amplification of the target marker gene to be sequenced
and ii) the addition of index sequences necessary for
sample multiplexing. These steps can be performed in a
single PCR or in two separate PCRs. No study has
addressed whether the increased number of laboratory
processing steps associated with a 2-step PCR protocol,
will leave samples more vulnerable to bacterial DNA
contamination from the laboratory than when following
a 1-step PCR protocol. The inverse relationship between
sample bacterial load and the impact of contamination
has been well documented in the literature by others [1,
2] and ourselves [3]. Thus, we predicted that while sam-
ples with a high bacterial load (i.e. upper airway samples)
would be able to buffer against protocol effects resulting
from differences in contamination levels, samples with a
low bacterial load (i.e. lower airway samples) would not
be resistant to these effects.
In addition to number of PCR steps, sequencing proto-
cols vary by choice of targeted marker gene region. Sev-
eral different 16S rRNA gene variable regions have been
targeted in studies of the lung microbiome, including V1
V2 [4, 5], V1 V3 [6–8], V3 V5 [7, 9–13], V3 [14, 15] and
V4 [16–19]. Choice of target marker gene region has
been limited by the short length of DNA that can be se-
quenced using the most common high-throughput se-
quencing technologies. The V4 region has increased in
popularity as studies on estimates of alpha- [20] and
beta- diversity [21] (i.e. measures of diversity within and
between samples, respectively) and taxonomic assign-
ments [22, 23] have collectively indicated that this site
generates the most accurate descriptions. In addition, its
relatively short length has allowed for the complete over-
lap of the forward and reverse sequencing read; advanta-
geous because correction of sequencing errors is
possible using the read with highest quality score [24].
The increased capacity of the MiSeq sequencer to se-
quence longer DNA sequences coupled with the devel-
opment of novel denoising strategies (e.g. DADA2 [25]),
has however led to an increased interest in the targeting
of the longer V3 V4 region. It is however unclear how
these results compare to earlier studies based on the
shorter V4 region.
In the current study, we sought to i) evaluate the im-
pact of bacterial DNA contamination when processing
samples through protocols that vary in number of PCR
steps (1- or 2-steps) and ii) determine the impact of
choice of target marker gene region (V3 V4 vs V4) on
the presentation of the upper and lower airway
microbiome. To address these issues we processed sam-
ples of both high and low bacterial load through three
library preparation setups varying in the number of PCR
steps and target marker gene region: Setup 1 (2-step
PCR; V3 V4 region), Setup 2 (2-step PCR; V4 region),
Setup 3 (1-step PCR; V4 region). The upper airways
were represented by oral wash (OW) samples and the
lower airways by protected specimen brushes (PSB) and
protected bronchoalveolar lavages (PBAL) collected by
bronchoscopy. Negative control samples (NCS) consist-
ing of saline used in the collection of all samples was




The study included 23 subjects from the MicroCOPD
study [26]. Subject characteristics are provided in
Table 1.
Number of sequences and amplicon sequence variants
(ASVs)
We began our analyses with a comparison of the num-
ber of sequences and amplicon sequence variants (ASVs)
retained at each step when processing through the bio-
informatic pipeline (Fig. 1). For sequencing setup 1, the
procedural samples were dispersed across four sequen-
cing runs (I-IV). For sequencing setups 2 and 3, two sep-
arate sequencing runs (one per setup) were conducted
including all samples.
As the sequences were passed through the different
bioinformatic filtering steps, the total number of se-
quences and ASVs across the three setups became more
similar. Denoising in DADA2 (Fig. 1, step 1) resulted in
the greatest decrease in sequence number. The greatest
decrease in ASV number occurred after the removal of
small ASVs, for which the number of sequences was cal-
culated to be less than 0.005% of the total number of se-
quences on the same run (Fig. 1, step 3). The drop in
ASV number was greatest for sequencing setups 1 and
2, both of which are based on the longer 2-step PCR
protocol.
After the final filtering step (Fig. 1, step 6), the
number of ASVs was significantly higher for setup 1
compared to that observed for setups 2 and 3. When
we restricted analyses to samples from the largest se-
quencing run in setup 1 (14 participants, 56 samples)
(Additional File 1: Fig. S.1.), the number of ASVs for
setup 1 was now more comparable to that observed
for setups 2 and 3 (Additional File 1: Fig. S.1., step
6). The higher number of ASVs still observed for
setup 1, was expected due to the greater taxonomic
resolution obtained when targeting a longer marker
gene region (V3 V4).
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Protocol effects on mock community sample
The mock community sample HM-783D, consisting of
genomic DNA from 20 different bacterial species (17
genera) was included on each sequencing run. For a
detailed presentation of the mock community, see Add-
itional File 7: Supplementary Methods. Because the pro-
tocols targeting different hypervariable regions result in
different ASVs, we describe ASVs obtained for setup 1
(V3 V4 target) and setups 2 and 3 (V4 target), separately.
When following setup 1 across four sequencing runs,
we obtained the following number of sequences and
ASVs: run I: 128,413 (27 ASVs); run II: 109,709 (23
ASVs); run III: 110,492 (24 ASVs) and run IV: 84,909
(27 ASVs). As the number of sequences obtained for
each run was similar, ASV numbers were also compar-
able across the four runs. While most genera were
defined by a single ASV, genera Escherichia, Staphylo-
coccus, Streptococcus, Clostridium and Rhodobacter were
defined by multiple ASVs. The major ASVs attributed to
each genus (i.e. those with the highest number of se-
quences) were the same across all four sequencing runs.
For a detailed presentation of the ASVs observed in the
mock community following setup 1, see Additional File 2:
Table S.1.
When following setups 2 and 3, we obtained 103,409
sequences (31 ASVs) and 120,073 sequences (23 ASVs),
respectively. The genera Escherichia, Staphylococcus,
Streptococcus, Clostridium and Neisseria were defined by
multiple ASVs. The major ASVs attributed to each
genus were the same in both setups 2 and 3. For a
detailed presentation of the ASVs observed in the mock
community following each setup, see Additional File 3:
Table S.2. and Additional File 4:Table S.3.
A summary of the expected and observed taxonomic
distribution in the mock community sample, obtained
for each setup is presented in Fig. 2 and Table 2. We
found that the three sequencing setups were for the
most part equally efficient at recovering high abundant
mock community members. Sequencing setup 3, was
least efficient at recovering the low abundant members.
Across all setups, we observed an increase in the relative
abundances of genera Escherichia and Staphylococcus
and a significant decrease in Rhodobacter compared to
that expected. All setups generated low abundant ASVs
that did not match to any of the expected taxa in the
mock community (i.e contaminants). Because the mock
community sample was included on each of the four
sequencing runs I-IV performed following setup 1, we
were also able to show that mock community sequen-
cing is reproducible.
Protocol effects on contamination profiles
Our working hypothesis linked protocol bias to differ-
ences in susceptibility to laboratory contamination. We
therefore proceeded with an examination of the average
top 20 ASVs found in NCS. Because the same DNA ex-
tracts were processed through each of the three setups,
any observed differences in taxonomic distribution
would be attributed to library preparation steps (post
DNA extraction). We also examined PCR water samples
included on each sequencing run. In contrast to NCS,
this later sample reflects contamination introduced dur-
ing library preparation steps without interference from
contaminating DNA introduced from the DNA extrac-
tion kit. ASVs obtained for setups 2 and 3, targeting the
V4 region and the single setup targeting the V3 V4
region are described separately.
The average top 20 ASVs observed in NCS in setups 2
and 3, are presented in Fig. 3. The samples were domi-
nated by many of the same taxa, and most of these taxa
were defined by the same ASVs. The Decontam package
(method = either, threshold = 0.5) applied downstream of
Table 1 Subject characteristics
Controls COPD Asthma
Subjects 9 10 4
Age, mean ± SD years 63.0 ± 6.7 68.2 ± 5.2 63.6 ± 3.1
Men 6 (66.7%) 8 (80.0%) 2 (50.0%)
Current-smokers 2 (22.2%) 1 (10.0%) 0
Former-smokers 5 (55.6%) 9 (90.0%) 3 (75.0%)
Never-smokers 2 (22.2%) 0 1 (25.0%)
Smoker pack years, mean ± SD years 11.8 ± 6.1 25.2 ± 8.1 12.1 ± 6.2
FEV1 (% predicted), mean ± SD 97.0 ± 13.7 72.6 ± 23.2 101.6 ± 9.3
Inhaled corticosteroids 0 2 (20.0%) 3 (75.0%)
LABA 0 3 (30.0%) 1 (25.0%)
LAMA 0 4 (40.0%) 0
COPD Chronic obstructive pulmonary disease; FEV1 Forced expiratory volume in 1 s; LABA Long-acting beta-agonist; LAMA Long-acting muscarinic antagonist. 1
smoker pack year = 20 cigarettes (one pack) smoked daily for 1 year. Age, smoker pack years and FEV1 (% predicted) are presented as the mean ± standard
deviation.SD: standard deviation.
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the presented data identified the majority of the top 20
ASVs presented in NCS as contaminants. Exceptions in-
cluded both ASVs mapping to the genus Streptococcus (in
line with our previous findings [3]) (using NCBI blastn
these ASVs were determined to be Streptococcus oralis
(06f825b512d903b9230e1a55d87359ee) and Streptococcus
thermophilus (fd496fd32dc8c08ade2e8b6c9d8ee13d) and
the single ASV mapping to the family Pasteurellaceae.
The distribution of ASVs in NCS (Fig. 3) differed
the most between setups 2 and 3 for an ASV belong-
ing to the family Enterobacteriaceae (mapped to
Escherichia using NCBI blastn), with a significant
increase observed in samples sequenced by setup 3
(0.02% observed for setup 2 and 29.34% observed for
setup 3). These findings were in accordance with the
results from the mock community analysis (Fig. 2),
for which the same Escherichia ASV was also found
at higher levels in the mock community sample se-
quenced by setup 3 (22.54% observed for setup 2 and
32.90% observed for setup 3). Its relatively high abun-
dance in the mock community processed through
setup 2 compared to NCS was expected as the
Escherichia genus defined by this ASV constituted
21.91% of the expected mock community profile; i.e.
Fig. 1 Comparison of the number of sequences and amplicon sequence variants (ASVs), retained at each bioinformatic filtering step for
procedural samples (PSB, PBAL, OW, NCS) collected from 23 participants (n = 92 samples). Setup 1 (2-step PCR; V3 V4 region), Setup 2 (2-step PCR;
V4 region), Setup 3 (1-step PCR; V4 region)






































































Fig. 2 Analysis of mock community HM-783D. The expected relative abundances of genera in the mock community sample is presented next to
that observed in the sequencing output across the three setups. The Escherichia genus consisted of ASVs classified to family level
(Enterobacteriaceae); ASV ffc36e27c82042664a16bcd4d380b286 dominated Setup 1 targeting the 16S rRNA gene V3 V4 region and ASV
d46e2205f0c6ecf67b51f83d111c509c dominated Setups 2 and 3 targeting the V4 region. Using the NCBI blastn tool we were able to confirm that
these ASVs belonged to the Escherichia coli genus. Bioinformatics processing steps were limited to DADA2, VSEARCH, taxonomy assignment and
removal of features not classified at minimum to phylum level. Setup 1 (2-step PCR; V3 V4 region), Setup 2 (2-step PCR; V4 region), Setup 3 (1-
step PCR; V4 region)
Table 2 Expected and observed relative abundance (%) of genera in mock community sample HM-783D. Setup 1 (2-step PCR; V3 V4
region); Setup 2 (2-step PCR; V4 region); Setup 3 (1-step PCR; V4 region)








Setup 2 Setup 3
Escherichia 21.91 27.68 23.99 25.20 26.65 22.54 32.90
Rhodobacter 21.91 5.98 9.52 9.23 8.94 11.00 8.77
Staphylococcus 24.10 29.02 29.27 29.66 30.56 29.88 24.98
Streptococcus 24.12 28.51 27.39 27.03 25.38 26.20 25.81
Bacillus 2.19 3.38 2.86 2.95 2.85 3.15 2.49
Clostridium 2.19 2.18 3.28 2.19 1.88 2.64 1.69
Pseudomonas 2.19 1.44 1.68 1.75 1.93 2.12 2.02
Acinetobacter 0.22 0.32 0.29 0.33 0.30 0.29 0.12
Helicobacter 0.22 0.36 0.49 0.44 0.38 0.61 0.26
Lactobacillus 0.22 0.22 0.20 0.23 0.24 0.35 0.18
Listeria 0.22 0.33 0.33 0.30 0.32 0.37 0.26
Neisseria 0.22 0.24 0.31 0.30 0.27 0.43 0.39
Propionibacterium 0.22 0.13 0.22 0.18 0.15 0.29 0.00
Actinomyces 0.02 0.01 0.01 0.00 0.00 0.01 0.00
Bacteroides 0.02 0.02 0.00 0.03 0.02 0.04 0.02
Deinococcus 0.02 0.02 0.04 0.03 0.02 0.03 0.02
Enterococcus 0.02 0.03 0.02 0.03 0.02 0.02 0.00
Other 0.00 0.13 0.11 0.10 0.09 0.03 0.08
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for this sample the ASV represented both a contam-
inant and a non-contaminant.
We proceeded with a comparison of the taxonomic
distribution in PCR water samples sequenced following
setups 2 and 3 (Table 3). A relatively low number of
sequences and ASVs were obtained (setup 2: 178
sequences (10 ASVs); setup 3: 130 sequences (6 ASVs)).
Importantly, the dominating ASV (35.38%) found in the
PCR water samples sequenced following setup 3, was the











































































































































































































































































































































































Fig. 3 Comparison of the 20 most abundant amplicon sequence variants (ASVs) observed in negative control samples (NCS) after sequencing
following setups 2 and 3. Taxa presented according to decreasing abundance for ASVs observed following setup 2. Bioinformatic processing
steps were performed up the removal of contaminants identified using Decontam. Taxonomic rank is described using prefixes (c__: class, o__:
order, f__: family, g__: genus). Setup 2 (2-step PCR; V4 region); Setup 3 (1-step PCR; V4 region). Data is presented as the average relative
abundance. Data unrarefied
Table 3 Relative abundance (%) of ASVs observed in PCR water samples in setups 2 and 3
ASV Lowest Classification Setup 2 Setup 3
06f825b512d903b9230e1a55d87359ee f__Streptococcaceae; g__Streptococcus 35.39 20.77
ddfd49f939f92958b1ec816741055348 f__Oxalobacteraceae; g__Ralstonia; s__ 12.36 0.00
394eda29c886632f514dd94b58381186 f__Pasteurellaceae 8.99 0.00
d32e579b3ae7b2aae8d5bf9f027c29af f__Comamonadaceae 8.99 0.00
5648dccee530d68ceb3e4d7d22cf8756 f__Pseudomonadaceae; g__Pseudomonas 7.87 0.00
4f5efd25dacb5d639316e7291ff6ff8b f__Neisseriaceae; g__Neisseria 7.87 7.69
85c44c83eddc5d3028261a1000b7d0e1 f__Gemellaceae 5.62 0.00
923f521b9cf313f1f95c9367e09bbc1c f__Veillonellaceae; g__Veillonella; s__dispar 5.62 12.31
dcba105f35d8ebc9e22269c7491ad3a7 f__Xanthomonadaceae; g__Stenotrophomonas; s__geniculata 5.06 0.00
df8456a1abbfb4c8a2c450b44378d4cb f__Actinomycetaceae; g__Actinomyces; s__ 2.25 0.00
d46e2205f0c6ecf67b51f83d111c509c* f__Enterobacteriaceae 0.00 35.38
edc9e5c16e40aff1eadce6597940f08f f__Streptococcaceae; g__Streptococcus; s__ 0.00 13.85
65d43491988bfe557da4d86a5ba25dae f__Staphylococcaceae; g__Staphylococcus 0.00 10.00
*Escherichia ASV also observed to differentiate mock community samples and NCS in setups 2 and 3. Bioinformatic processing steps were performed up until the
removal of contaminants identified using Decontam. Taxonomic rank is described using prefixes (f__: family, g__: genus, s__: species)
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same ASV was not found in the PCR water sample se-
quenced by setup 2. Together these findings indicate
that the Escherichia ASV is a contaminant introduced
during steps of library preparation using a reagent that
is exclusive to setup 3.
We next looked at the average top 20 ASVs observed
in NCS when sequencing following setup 1 (Fig. 4). The
taxonomic profiles obtained after sequencing the longer
V3 V4 region resulted in greater taxonomic resolution
compared to that observed when sequencing the V4 re-
gion in setups 2 and 3. Whereas the three ASVs belong-
ing to the family Enterobacteriaceae classified down to
genus level Gluconacetobacter in setup 1, the Enterobac-
teriaceae ASVs classified no lower than to family level in
setups 2 and 3 (Fig. 3). The cumulative average relative
abundance of the three ASVs mapping to Gluconaceto-
bacter when following setup 1 (22%) was however the
same as that found for the single ASV mapping to the
family Enterobacteriaceae when following setup 2 (23%).
Thus, for these two setups, the contamination profiles
were similar although greater resolution was obtained
when sequencing a longer target gene region in setup 1
(V3 V4).
Protocol effects on procedural samples
We next compared the sequencing output obtained for
the procedural samples sequenced following each of the
three setups. Because we suspected that any differences
observed between sequencing setups could be explained
by differences in susceptibility to laboratory contamin-
ation, comparisons were made both before and after the
removal of contaminants identified in Decontam (Fig. 1,
Step 5).
Before the removal of Decontam contaminants (Fig. 5),
we found that across all three sequencing setups, pro-
cedural samples (OW, PSB, PBAL) were dominated by
many of the same taxa. The most prominent taxa aver-
aged across all samples in order of decreasing relative
abundance were genera Streptococcus, Prevotella, Veillo-
nella and Rothia. We interpreted these as representative
of the authentic airway microbiota based on the growing
body of literature for which these same taxa have been
consistently observed in airways.
Several less abundant taxa for which we interpreted as
contaminants, based on their dominance in NCS were
also observed in the data. We previously learned that
ASVs attributed to the family Enterobacteriaceae domi-
nated the NCS and that an ASV mapping to Escherichia
had a discriminating impact on NCS and mock commu-
nities processed through setup 3. We were therefore
particularly interested in understanding whether Entero-
bacteriaceae would also have a discriminating impact on
procedural samples processed through the different se-
quencing setups. Across all three sequencing setups we
found that the levels of Enterobacteriaceae was highest
in samples from the lower airways (PSB > PBAL) and
nearly undetected in OW samples (Fig. 5). The higher
levels of Enterobacteriaceae in PSB samples compared to
PBAL, was expected as less sample volume was used as
input to the DNA extraction protocol (450 μl PSB vs
1800 μl PBAL) thereby securing a lower bacterial load in



































































































































































































































































































































































Fig. 4 The 20 most abundant amplicon sequence variants (ASVs) observed in negative control samples (NCS) after sequencing following setup 1.
Multiple ASVs mapped to genera Gluconacetobacter, belonging to familiy Enterobacteriaceae (cummulative 22%). Bioinformatic processing steps
were performed up until the removal of contaminants identified using Decontam. Taxonomic rank is described using prefixes (c__: class, o__:
order, f__: family, g__: genus). Data is presented as the average relative abundance. Data unrarefied
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relative abundance of Enterobacteriaceae was highest
when sequencing following setup 3; this was also in ac-
cordance with our results when sequencing the mock
community and likely due to the additional Escherichia
contamination introduced during library preparation fol-
lowing setup 3 (Fig. 3). The relative abundance of En-
terobacteriaceae per sample is provided in the
Additional File 5: Table S.4. By analysis of beta-diversity
using the unweighted UniFrac metric, we were able to
confirm that there was greater overlap or similarity
between the bacterial communities found in NCS and
procedural samples from the lungs when sequencing
following setup 3 (Additional File 6: Fig. S.2).
After the removal of Decontam contaminants, the less
abundant taxa that we predicted as representative of
contaminants had been filtered out (Fig. 6). Although
the dominating taxa across all samples were now mainly
expected core airway microbiota members, the relative
abundances of these taxa still varied across the three
setups.
A direct comparison of the bacterial communities re-
covered when sequencing by a 1 or 2 step PCR protocol
was achieved by analysis of beta-diversity (using the un-
weighted UniFrac metric) on samples processed through
each of setups 2 and 3. Before the removal of Decontam
contaminants, OW and NCS clustered together regard-
less of whether they had been processed through setups
2 or 3 (Fig. 7). The samples from the lungs however
clustered separately according to the protocol for which
they were processed. When Decontam contaminants
were removed, the samples from the lungs processed by
setups 2 and 3 became more similar in bacterial commu-
nity composition, as indicated by a greater degree of
overlap in PCoA space (Fig. 8). The separation of the
lower airway samples based on the setup for which they
were processed was however still apparent. This indi-
cated that mechanisms related to the low bacterial load,
other than differences in contamination were driving the
observed protocol bias. For analysis of beta-diversity
using the weighted UniFrac metric before and after
removal of Decontam contaminants, see Additional File 8:
Fig. S.3 and Additional File 9: Fig. S.4, respectively.
Discussion
We have shown that choice of library preparation proto-
col for high-throughput amplicon-based sequencing of
the 16S rRNA gene (1-step PCR vs 2-step PCR) will have
an impact on final bacterial community descriptions for
airway samples - and more so for samples of low bacter-
ial load. Differences observed when sequencing the dif-
ferent target regions (V3 V4 and V4) appeared to be
relatively small in comparison, and mainly attributed to
differences in taxonomic resolution. Using bioinformatic
filtering parameters, we were able to reduce but not
completely remove the differences in sequencing output
observed for the three sequencing setups: Setup 1 (2-
Fig. 5 Taxonomic distribution obtained for procedural samples before the removal of Decontam contaminants. ASVs attributed to the family
Enterobacteriaceae, had dominated the NCS across all setups. In the procedural samples, Enterobacteriaceae was observed with the following
relative abundances in setups 2 and 3: setup 2 (OW: 0%; PBAL: 0.83%; PSB: 5.23%); setup 3 (OW: 0.01%; PBAL: 1.87%; PSB: 7.51%). ASVs attributed
to the genus Gluconacetobacter within the family Enterobacteriaceae was observed in procedural samples with the following relative abundances
in setup 1 (OW: 0%; PBAL: 1.42%; PSB: 6.32%). Samples with fewer than 1000 sequences had been omitted from the analyses leaving the
following number of samples in each setup: Setup 1 (OW: n = 22; PBAL: n = 23; PSB: n = 23); Setup 2 (OW: n = 23; PBAL: n = 23; PSB: n = 23);
Setup 3 (OW: n = 23; PBAL: n = 21; PSB: n = 22). Setup 1 (2-step PCR; V3 V4 region); Setup 2 (2-step PCR; V4 region); Setup 3 (1-step PCR; V4
region). Taxonomic rank is described using prefixes (p__: phyla; c__: class; o__: order; f__: family; g__: genus)
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step PCR; V3 V4), Setup 2 (2-step PCR; V4) and Setup 3
(1-step PCR; V4). We propose that protocol bias in stud-
ies of the lung microbiome are related not only to differ-
ences in susceptibility to contamination but also to less
understood (and largely ignored) mechanisms of PCR
bias.
Beginning with a comparison of the number of se-
quences and ASVs retained at each bioinformatic pro-
cessing step, we gained insight into the differences in the
sequencing output generated for each of the three
setups. We found that the removal of small ASVs re-
sulted in the greatest decrease in total ASV number
across all three setups - with greatest impact on data
generated from the two sequencing setups based on the
2-step PCR protocol (setup 1 and 2). Our interpretation
was that the small ASVs likely represent low abundant
contamination and that the observed higher frequencies
in data generated when processing through longer la-
boratory workflows was as predicted. Interestingly, this
filtering step was originally recommended for filtering
out spurious operational taxonomic units (OTUs) de-
rived from PCR and sequencing error [27], and therefore
not regarded as necessary after denoisning to ASVs [28].
The total number of ASVs after the removal of small
ASVs, was still markedly higher when sequencing was
performed following setup 1, for which samples were
spread across four different sequencing runs. We can ex-
pect contamination profiles to vary across sequencing
runs, thereby adding to the number of ASVs in the data
set, and we therefore interpreted the higher number of
ASVs as contamination that had not been filtered out.
When analyses were conducted on the subset of samples
sequenced on the same run, we still observed a slight in-
crease in ASV count in setup 1; this likely attributed to
the greater taxonomic resolution obtained when sequen-
cing a larger gene region. Based on the raw sequencing
data, the take home message is therefore that researchers
need to pay particular attention to small ASVs when
making comparisons across datasets sequenced following
different protocols. The observed inflation of ASVs when
sequencing across multiple sequencing runs also needs
to be accounted for.
By sequencing of a mock community sample, we were
able to show that the three sequencing setups were for the
most part equally efficient at recovering the high abundant
mock community members. For reasons that are unclear
to us, we found that sequencing setup 3, was least efficient
at recovering the low abundant members. Together with
Fig. 6 Taxonomic distribution obtained for procedural samples after the removal of Decontam contaminants. Samples with fewer than 1000
sequences were omitted. Number of samples in each setup: V3V4 protocol A (OW: n = 22; PBAL: n = 22; PSB: n = 21), V4 protocol A (OW: n = 23;
PBAL: n = 22; PSB: n = 20); V4 protocol B (OW: n = 23; PBAL: n = 21; PSB: n = 21). Setup 1 (2-step PCR; V3 V4 region); Setup 2 (2-step PCR; V4
region); Setup 3 (1-step PCR; V4 region). Taxonomic rank is described using prefixes (p__: phyla; c__: class; o__: order; f__: family; g__: genus)
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Fig. 7 Principal coordinates analysis on unweighted UniFrac distances for procedural samples sequenced following setup 2 (sphere) and 3
(diamond) before the removal of Decontam contaminants. Rarefaction depth: 1066 sequences. Setup 2 samples include OW: n = 23; PBAL: n = 23;
PSB: n = 23; NCS: n = 21 and setup 3 samples include OW: n = 23; PBAL: n = 21; PSB: n = 22; NCS: n = 18. Oral Wash (OW): blue; Protected
bronchoalveolar lavage (PBAL): green; Protected specimen brushes (PSB): purple; Negative control samples (NCS): red. Setup 2 (2-step PCR; V4
region), Setup 3 (1-step PCR; V4 region)
Fig. 8 Principal coordinates analysis on unweighted UniFrac distances for procedural samples sequenced following setup 2 (sphere) and 3
(diamond) after the removal of Decontam contaminants. Rarefaction depth: 1139 sequences. Setup 2 samples include OW: n = 23; PBAL: n = 22;
PSB: n = 20 and setup 3 samples include OW: n = 23; PBAL: n = 21; PSB: n = 21. Oral Wash (OW): blue; Protected bronchoalveolar lavage (PBAL):
green; Protected specimen brushes (PSB): purple. Setup 2 (2-step PCR; V4 region), Setup 3 (1-step PCR; V4 region)
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the observation that the total number of ASVs recovered
following setup 3 was lower than for Setups 1 and 2, we
concluded that the 1 step-PCR protocol may be less apt
for detecting rare but potentially significant taxa [29, 30].
Berry et al. [31] also compared sequencing data generated
when processing samples through PCR protocols that dif-
fered in the number of PCR steps (1-step PCR vs 2-step
PCR). In accordance with our findings, they observed re-
duced richness when processing samples through the 1-
step PCR protocol. Thus, it could be that although the 1-
step PCR protocol may generate data less influenced by
small contaminating ASVs, measures of alpha diversity
may be underestimated.
To further explore the potential impact of contamin-
ation, we compared the contamination profiles (based
on NCS) obtained for the three sequencing setups. We
were surprised to find that the NCS samples processed
through setup 3 were dominated by an ASV mapping to
Escherichia coli (family Enterobacteriaceae). It was unex-
pected because we have previously traced the main
source of contamination in the MicroCOPD study to the
DNA extraction kit [3]. Because the same DNA extracts
were used as input into the sequencing setup 3, we ex-
pected that the lower number of laboratory processing
steps compared to setups 1 and 2, would secure a con-
taminant profile representative of that introduced during
DNA extraction. We however learned that a contamin-
ant introduced during library preparation was enough to
overwhelm the contamination profile of the entire se-
quencing run. We immediately suspected that the DNA
polymerase, manufactured in Escherichia coli and used
exclusively in the PCR amplification step when sequen-
cing following setup 3, was the main contamination
source. Our findings emphasize the fact that researchers
must be meticulous in their choice of PCR reagents and
also aware of these effects when comparing data gener-
ated using different protocols.
We have previously determined the sample bacterial
load for the samples included in the current study, and
estimated that contaminants will represent 10–50% of
the sequencing output for lower airway samples when
sequencing by setup 1 [3]. We found that the Enterobac-
teriaceae family represented less than 10% of the tax-
onomy profiles for the procedural samples in all three
setups and recognized that a significant fraction of the
contaminants, were likely also represented by small
ASVs and other taxa. For a more accurate assessment of
the impact of contamination, we therefore also relied on
the Decontam R package [32] for the identification of
contaminants. We predicted that if contamination was
the main distinguishing factor causing the separation in
sequencing output across sequencing setups, the re-
moval of Decontam contaminants would close this gap.
By analysis of unweighted Unifrac distances in PCoA
space, both before and after the removal of Decontam
contaminants, we observed that while the high biomass
OW samples clustered together, the low biomass sam-
ples from the lungs (PBAL,PSB) separated according to
the setup 2 or 3, for which they had been processed. We
concluded that factors related to bacterial load, other
than contamination must also be contributing to the
observed protocol bias.
The polymerase chain reaction (PCR) lies at the core
of all amplicon-based sequencing protocols. The impact
of PCR related bias (i.e. all mechanisms that may lead to
the preferential amplification of particular sequences or
taxa) on studies involving samples holding a low bacter-
ial load is however not well understood. This despite
that recent papers as well as research dating back even
two decades has documented that PCR related bias ap-
pears to increase with decreasing template DNA concen-
tration [1, 33–35]. Kennedy et al. [35] observed that
bacterial community profiles of replicate soil samples de-
creased in similarity after sample dilution. The authors
attributed these observations to an increased impact of
stochastic fluctuations in PCR amplifications at lower
bacterial loads. Biesbroek et al. [1] observed an increase
in Firmicutes and decrease in Bacteriodetes across a seri-
ally diluted saliva sample, but were unable to explain the
direct mechanism behind their observations. Our study
contributes to the literature addressing these issues by
demonstrating that samples of high bacterial load (OW)
appear to be able to buffer against protocol bias (i.e.
differences in number of PCR steps), while samples of
low bacterial load (PSB, PBAL) are directly impacted.
More research is needed in order to understand the
extent to which these mechanisms are responsible for
our observations.
The results presented in the current study have several
important implications. Because the upper respiratory
tract represents both i) a major potential source of con-
tamination under sampling and ii) the main source com-
munity for the lung microbiota, most studies include
representative samples from this site (e.g. OW samples)
[4, 17, 19, 36, 37]. Our findings demonstrate that the ob-
served overlap between the bacterial communities of the
upper and lower respiratory tract may be protocol
dependent. Of concern is also that similar community
descriptions obtained for upper respiratory tract samples
across protocols may mistakenly be interpreted as evi-
dence that datasets are comparable also for lower re-
spiratory tract samples. Our findings also lead us to
question the conclusions made in studies where similar
PCR reagents have been used. Dickson et al. [12] have
for example suggested that Escherichia coli may be a
significant lung pathogen that has previously gone
undetected using culture-based techniques. Our results
open for interpreting the bacterium as a contaminant
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introduced with the recombinant DNA polymerase used
in the PCR.
We acknowledge that there are limitations to our
study. First of all, we did not collect control samples
from the bronchoscope working channel used to obtain
PBAL and PSB samples. We have however conducted
such analyses in our previous publication [3], and shown
the DNA extraction kit is the main contamination
source for setup 1. For the current work, we focus on
PCR protocol steps post-DNA extraction. Because the
same DNA extracts were used as input to the three li-
brary preparation setups being compared, contamination
from earlier steps of the pipeline would affect samples
similarly in the different setups. Another limitation is
that library preparation and sequencing for each setup
was not repeated, and assessement of reliability therefore
limited. However, our analyses of the mock community
sample, for which was included on all three setups (and
processed four times through setup 1), indicated that
valid comparisons could be made across setups.
Conclusion
Our findings show that choice of protocol for library
preparation and sequencing (1- or 2- steps of PCR) will
have an impact on the analyses of the airway micro-
biome. Upper airway samples (high biomass) were less
impacted than lower airway samples (low biomass), indi-
cating that protocol bias is related to sample biomass.
This did not appear to be associated with differences in
contamination levels when following a longer or shorter
protocol, but rather to mechanisms related to the PCR,
for which more research is required. These methodo-
logical limitations likely explain the variable conclusions
across studies of the airway microbiome (e.g. for com-
parisons of upper and lower airway samples). Differences
in targeted amplicon region (16S rRNA gene V3 V4
versus V4) did not appear have a great impact on final
bacterial community descriptions, although greater
taxonomic resolution was observed when targeting the
longer V3 V4 region.
Methods
Study samples
The 23 study subjects were chosen from the Bergen
COPD Microbiome Study (short name “MicroCOPD”)
for representation of both healthy (n = 9) and diseased
(asthma (n = 4), COPD (n = 10)) states. Out of the 350
study subjects included in the MicroCOPD study (with
samples dispersed across over 30 sequencing runs), the
subset of subjects included in the current investigation
were chosen in order to minimize the spread of samples
across multiple runs. Details on the MicroCOPD study
design and bronchoschopy procedures have been previ-
ously published [26]. The MicroCOPD study was
approved by the regional ethical committee (REK-Vest,
case # 2011–1307), and all subjects signed written
informed consent.
In brief, voluntary bronchoscopies were performed on
adult subjects (with and without obstructive lung disease)
recruited from Western Norway between 2013 and 2015,
at the Department of Thoracic Medicine, Haukeland Uni-
versity Hospital. Subjects were examined in the stable
state and were not to have received antibiotics at mini-
mum 2weeks prior to the procedure. Samples collected
under each procedure included the first and second frac-
tion of 2 × 50mL protected (through a sterile inner cath-
eter passed through the scope channel) bronchoalveolar
lavage (PBAL1 and PBAL2) from the right middle lobe,
three protected specimen brushes sampled from the right
lower lobe (PSB), an oral wash (OW) sample, and a nega-
tive control sample (NCS) taken from the sterile bottle of
phosphate buffered saline directly; the same fluid used for
BAL sampling, OW, and dissolution of the PSBs.
We also included a mock community sample, obtained
through BEI Resources NIAID, NIH as part of the Human
Microbiome Project: Genomic DNA from Microbial
Mock Community B (Staggered, Low Concentration),
v5.2L, for 16S rRNA Gene Sequencing, HM783D.
Bacterial DNA extraction
Bacterial DNA extraction was performed first by treat-
ment with lytic enzymes mutanolysin, lysozyme and
lysostaphin (all from Sigma-Aldrich, St. Louis, MO,
USA) and subsequently by processing through the Fast
DNA Spin Kit (MP Biomedcals, LLC, Solon, OH, USA)
following the manufacturer’s instructions. The sample
volume used as input into the DNA extraction protocol
varied with sample type; 450 μl for PSB and NCS and
1800 μl for OW and PBAL.
Library preparation for MiSeq sequencing
We processed the same DNA extracts through three dif-
ferent library preparation setups for MiSeq sequencing
of the bacterial 16S rRNA marker gene: Setup 1 (2-step
PCR; 16S rRNA gene region V3 V4); Setup 2 (2-step
PCR; 16S rRNA gene region V4); Setup 3 (1-step PCR;
16S rRNA gene region V4). Setups 1 and 2, were based
on the 2-step PCR protocol described in the Illumina
16S Metagenomic Sequencing Library Preparation guide
(Part no. 15044223 Rev. B). In the first PCR, the 16S
rRNA gene regions V3 V4 (setup 1) and V4 (setup 2)













PCR cycling was performed with an initial cycle at
95 °C for 3 min followed by 45 cycles of 95 °C for 30s,
55 °C for 30 s (setup1)/ 50 °C (setup 2), 72 °C for 30 s
and a final extension cycle at 72 °C for 5 min. In the sec-
ond PCR (8 cycles), index sequences were added to the
ends of the amplicons generated in the first PCR, using
primers from the Nextera XT Index Kit (Illumina Inc.,
San Diego. CA, USA). Amplifications were performed
using the Kappa HiFi HotStart ReadyMix (KAPA Biosys-
tems, USA). Setup 3 was based on the 1-step PCR proto-
col described in Kozich et al. [24], with modifications
(see Additional File 7: Supplementary Methods). The
primers used targeted the 16S rRNA gene region V4 and
consisted of both gene specific sequences (underlined)







PCR cycling was performed with an initial cycle at
95 °C for 2 min followed by 45 cycles of 95 °C for 20 s,
55 °C for 15 s, 72 °C for 5 min and a final extension cycle
at 72 °C for 5 min. Amplifications were performed using
the recombinant DNA polymerse Accuprime Pfx Super
Mix (Thermo Fisher Scientific, USA).
Bioinformatics
General Steps. Sequences were processed using plugin
tools available within the Quantitative Insights Into Mi-
crobial Ecology (QIIME2) bioinformatic package (release
2019.1). Two fastq-files per sample (demulitiplexed,
paired-end reads) were imported into the QIIME2 envir-
onment. Using the dada2 denoise-paired plugin i) pri-
mer sequences and low quality bases at read-ends were
trimmed off, ii) paired-end reads were joined, iii) chi-
meras discarded and iv) amplicon sequence variants
(ASVs) inferred [25, 28]. Additional chimera filtering
was performed using the vsearch uchime-denovo plugin
[38]. ASVs with fewer sequences than 0.005% of the total
number of sequences and ASVs not found in at least
two samples were then discarded [27]. Taxonomy was
assigned using the feature-classifier classify-sklearn plu-
gin together with a Naïve Bayes classifier that had been
pre-trained on the full-length Greengenes 13_8 99%
OTU reference database (available on qiime2.org). ASVs
classified as mitochondria, chloroplasts or archaea were
discarded together with classifications that ended above
the phylum level. Contaminant ASVs identified using
the Decontam package in R were then discarded [32].
The Decontam method “either” (threshold = 0.5) was
chosen based on our previous work [3]. As the study
samples were found across multiple sequencing runs,
bioinformatics processing of samples was performed in
batches according to run number. Samples not included
in the study, but present on the same run were also in-
cluded in the pipeline to optimize performance of run
specific algorithms (e.g. DADA2 and Decontam). Ana-
lyses. Analysis on taxonomic composition was per-
formed in Excel on ASV tables generated at various
stages of the bioinformatic pipeline. Analyses on proced-
ural samples (PSB, PBAL, OW) were performed on the
ASV table processed through all general steps described
above. Analyses on the top 20 ASVs found in NCS and
in PCR water controls, were based on the ASV table
processed through all steps in the pipeline except re-
moval of contaminants identified in Decontam. For ana-
lyses on mock community samples, processing steps
were limited to DADA2, VSEARCH and removal of
ASVs not classified at minimum to phylum level. Ana-
lyses of beta-diversity were conducted using PCoA on
unweighted UniFrac distances. The unweighted UniFrac
metric scores samples with bacterial communities found
at similar positions within the phylogenetic tree, as more
similar than samples with bacterial communities found
at different positions within the tree. The (dis)similarity
between samples is visualized in principal coordinates of
analysis (PCoA) space, with samples similar in bacterial
composition plotted closer together. The unweighted
UniFrac metric was chosen to ensure that the less abun-
dant ASVs would have equal impact on the clustering
pattern as the high abundant ASVs.
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